It is defined by elevated serum AFP (>20 ng/mL) or immunohistochemical evidence of AFP expression, and is associated with larger tumor size, frequent vascular and lymphatic invasion, and high liver metastasis rates (33%–72%) (3–5). Here, AFP is linked to neoplasm.